Finally, even though RA190 can directly induce apoptosis of cancer cells (Supplementary Figure S5), we showed that the current RA190 treatment regimen can also reduce ID8 tumor growth and enhance survival in a CD8+ T cell-dependent manner. Here, CD8A is linked to neoplasm.